Hibernation-like therapy for stroke recovery after clot removal
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if a hibernation-like therapy can improve recovery after a stroke caused by a large blood clot in the brain. It is for people who are having a stroke and are scheduled for a procedure to remove the clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You had a stroke and are within 24 hours of when you were last seen well
- You are able to have a procedure to remove a blood clot from a large artery in the front part of your brain
- You did not have major disability before the stroke
- You do not have bleeding in the brain, certain heart or lung diseases, or serious infections
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a combination of two medicines (chlorpromazine and promethazine) to put the body into a 'hibernation-like' state can help people having a severe stroke. You will also receive standard clot-removal treatment, and the study hopes to see if this approach improves recovery.
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can help people recover better after having a stroke caused by a large clot in the front part of the brain. It is for people who recently had a clot removal procedure and have some remaining disability but are still awake and aware.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests giving a clot-dissolving medicine (rhPro-UK) through a vein before a procedure to remove a large blood clot in the brain. It is for people who had a stroke 4.5 to 24 hours ago and are already scheduled for clot removal. The goal is to see if the medicine helps improve blood flow and outcomes.
This study tests a combination of gentle brain-protecting treatments (temperature, oxygen, positioning, and nerve stimulation) given alongside standard clot-busting therapy for recent strokes. The goal is to see if the combination can help improve recovery and reduce disability after a stroke.
This study tests whether a clot-busting drug called pro-urokinase can help people with a stroke in the back of the brain when given later than usual (4.5 to 9 hours after symptoms start). The goal is to see if it improves recovery and reduces disability.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.